Dow Down 1.44% Nasdaq Down 1.78%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
10.37 Down 0.22(2.08%) 3:12PM EDT - Nasdaq Real Time Price
Prev Close:10.59
Open:10.63
Bid:10.40 x 700
Ask:10.41 x 800
1y Target Est:15.27
Beta:1.75
Next Earnings Date:24-Oct-14IMGN Earnings announcement
Day's Range:10.31 - 10.79
52wk Range:10.28 - 18.19
Volume:605,652
Avg Vol (3m):811,300
Market Cap:890.86M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGNDown 2.08%890.86M
PFEDown 1.66%184.39B
RHHBYDown 0.70%249.58B
SGENDown 1.88%4.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback